The Global Atopic Dermatitis Drugs Market Should Grow With a CAGR of 4.77% Over the Forecast Period. The Base Year Considered for the Study Is 2017 and the Forecast Period Is 2019-2027.

1. ATOPIC DERMATITIS DRUGS
Forecast2019-2027

3. • According to market expectations, the global atopic
dermatitis drugs market should grow with a CAGR of
4.77% over the forecast period. The base year
considered for the study is 2017 and the forecast
period is 2019-2027.
• The global atopic dermatitis drugs market is primarily
driven by factors such as the increasing prevalence of
food allergies causing atopic dermatitis, the rising
focus on systematic therapies and the ever increasing
use of pharmacological products in developing
countries

4. • The important driver increasing growth in the global atopic
dermatitis drugs market is the high prevalence of food
allergies exacerbating atopic dermatitis.
• It is estimated that food allergy and severe atopic dermatitis
coexist in about one-third of all children with atopic
dermatitis.
• The atopic dermatitis drugs market is broadly classified into
two segments on the basis of drug classes and the route of
administration.

6. “Global atopic dermatitis drugs market should grow with a CAGR
of 4.77% over the forecast period. The base year considered for
the study is 2017 and the forecast period is 2019-2027”

7. The North American market for atopic dermatitis
drugs is the largest in the world with an expected
CAGR of 4.17% for the forecast period of 2019-2027.

8. Experts have estimated that a high number of
people belonging to the European population
suffer from conditions such as conjunctivitis,
skin allergies and food allergies. The market for
atopic dermatitis drugs in Europe is, therefore
expected to showcase a CAGR of 3.30% over
the forecast period of 2019-2027.

9. According to market forecasts for 2019-2027, the
Asia Pacific market for atopic dermatitis drugs seems
to be growing at a faster rate than all other regional
markets with a CAGR of 7.57%. The main reason for
this may be the lack of proper hygiene and the
prevalence of allergic conditions in the population of
this area.

10. Leading players in the global atopic dermatitis
drug market are Allergan Plc, Aqua
Pharmaceuticals (An Almirall Company), Astellas
Pharma Inc., Bayer Ag, Biofrontera Ag,Bristol-
Myers Squibb,Stiefel Laboratories Inc, Encore
Dermatology, Galderma Sa, Leo Pharma, Meda
Pharmaceuticals (Mylan N.V.),Novartis Ag, Pfizer,
Regeneron Pharmaceuticals, Sanofi Sa, Valent
Pharmaceutical Inc. and several others.